USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF DRY EYE SYNDROME

• 收藏
• 分享

专利权人:

XIGEN INFLAMMATION LTD.

发明人:

COMBETTE, JEAN-MARC,DELOCHE, CATHERINE

申请号：

SG11201402347Y

公开号：

SG11201402347YA

申请日:

2012.11.30

申请国别(地区):

SG

年份:

2014

代理人:

摘要：

The present invention refers to the use of protein kinase inhibitors and more specifically to the use of inhibitors of the protein kinase c-Jun amino terminal kinase, JNK inhibitor (poly-)peptides, chimeric peptides, or of nucleic acids encoding same as well as pharmaceutical compositions containing same, for the treatment of dry eye syndrome.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/